GLS1 inhibitors for treating disease
US9809588B2 · kind B2 · utility
15Cited by
4References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 2, 2015 |
| Grant date | Nov 7, 2017 |
| Priority date | — |
| Expiry date | Jul 2, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D493/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are compounds and compositions useful in the treatment of GLS1 mediated diseases, such as cancer, having the structure of Formula I:Methods of inhibition GLS1 activity in a human or animal subject are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.